The Dutch cannabis experiment explained

Short answer

If you have visited coffeeshops in different Dutch cities, you may have noticed that the rules are not identical everywhere. One reason is an ongoing government trial: the closed cannabis supply chain experiment.

Information · not for sale Pillar: The cannabis experiment

The problem it addresses

Dutch policy has contained a structural flaw for decades. Selling cannabis in coffeeshops is tolerated, but cultivating and supplying it is prohibited. Coffeeshops therefore had to sell legally what they had bought illegally.

That created problems. There were no quality requirements, so customers could not know what was in a product. And cultivation remained in the criminal sphere.

What the experiment does

A limited number of growers have been designated by the government to cultivate cannabis under strict conditions. They supply the coffeeshops in the participating municipalities. In those municipalities, all coffeeshops take part. Participation is mandatory, not a choice, and not a mark of quality.

Around 75 coffeeshops are involved in total.

The participating municipalities

Arnhem · Almere · Breda · Groningen · Heerlen · Maastricht · Nijmegen · Tilburg · Voorne aan Zee · Zaanstad

What changes in practice

  • Products come only from designated growers.
  • Packaging carries product information, including the content of active compounds.
  • Products are tested for contaminants such as pesticides, heavy metals and moulds.
  • Origin is registered and traceable.

What does not change

All other conditions still apply: 18 and over with valid ID, a maximum of five grams per person per day, no alcohol, no hard drugs, no nuisance and no advertising.

What it does not mean

Participation means production, supply and sale are regulated under conditions. It does not mean cannabis use is legal, safe or recommended by the government.

Sources

Government of the Netherlands · Trimbos Institute · NVWA

This article is general information and not advice. Cannabis use is not without risk. For independent information and help, contact the Trimbos Institute, Drugsinfo or your doctor.